-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga·10/29/2024 16:30:59
Listen to the news

Gainers

  • GlycoMimetics (NASDAQ:GLYC) stock moved upwards by 189.9% to $0.49 during Tuesday's regular session. The market value of their outstanding shares is at $31.4 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 51.9% to $1.99. The company's market cap stands at $4.4 million.
  • GeneDx Hldgs (NASDAQ:WGS) shares increased by 48.0% to $82.97. The market value of their outstanding shares is at $2.2 billion. As per the press release, Q3 earnings came out today.
  • Ensysce Biosciences (NASDAQ:ENSC) shares moved upwards by 28.9% to $0.43. The company's market cap stands at $6.3 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) stock moved upwards by 25.54% to $1.67. The market value of their outstanding shares is at $4.9 million.
  • Innovative Eyewear (NASDAQ:LUCY) stock rose 24.08% to $7.42. The market value of their outstanding shares is at $17.8 million.

Losers

  • TransMedics Gr (NASDAQ:TMDX) shares decreased by 31.6% to $86.3 during Tuesday's regular session. The company's market cap stands at $2.8 billion. As per the press release, Q3 earnings came out yesterday.
  • Coya Therapeutics (NASDAQ:COYA) shares declined by 22.97% to $7.85. The market value of their outstanding shares is at $130.3 million.
  • Biora Therapeutics (NASDAQ:BIOR) stock fell 21.05% to $3.49. The market value of their outstanding shares is at $12.8 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares fell 19.83% to $0.25. The market value of their outstanding shares is at $7.6 million.
  • Bone Biologics (NASDAQ:BBLG) shares decreased by 19.66% to $1.39. The market value of their outstanding shares is at $2.5 million.
  • Aditxt (NASDAQ:ADTX) stock declined by 17.47% to $0.59. The market value of their outstanding shares is at $2.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.